Cargando…
Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot Study
Aim: Due to the fact that NRXN1 is associated with neurodevelopmental disorders, the aim of this study was to investigate the role of the NRXN1 gene in the etiology and epigenetics of depression by comparison of NRXN1 mRNA expression and NRXN1 protein level expression in patients suffering from depr...
Autores principales: | Skiba, Aleksandra, Talarowska, Monika, Szemraj, Janusz, Gałecki, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303668/ https://www.ncbi.nlm.nih.gov/pubmed/34357104 http://dx.doi.org/10.3390/jpm11070637 |
Ejemplares similares
-
ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder
por: Talarowska, Monika, et al.
Publicado: (2014) -
Expression of Selected Genes Involved in Neurogenesis in the Etiopathogenesis of Depressive Disorders
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2021) -
The role of interleukin genes in the course of depression
por: Talarowska, Monika, et al.
Publicado: (2016) -
Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression
por: Talarowska, Monika, et al.
Publicado: (2016) -
Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study
por: Jasionowska, Justyna, et al.
Publicado: (2019)